Related Experiment Video
Updated: Aug 15, 2025

07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
14.4K
Soft-Tissue Sarcomas in Adults in Ecuador in the Period 2010-2020
Xavier Sánchez1,2, Andrés Moreno Roca1,2,3, Ruth Jimbo-Sotomayor1,2
1Centro de Investigación Para la Salud en América Latina (CISeAL), Quito, Ecuador.
Sarcoma
|January 5, 2023
Summary
Soft-tissue sarcomas (STSs) are rare in Ecuador, with stable morbidity and mortality rates over the past decade. Further national studies are crucial for understanding prevalence and reducing deaths from these rare tumors.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Soft-tissue sarcomas (STSs) are uncommon adult malignancies, accounting for approximately 1% of all tumors.
- Surgical intervention remains the primary treatment modality for STSs.
- Advancements in diagnostic techniques aid in differentiating various STS subtypes.
Purpose of the Study:
- To analyze the morbidity and mortality trends of soft-tissue sarcomas in Ecuador.
- To provide an epidemiological overview of STS cases and deaths between 2010 and 2020.
Main Methods:
- A cross-sectional study design was employed.
- National databases were utilized to gather data on adult STS patients.
- The study period spanned from 2010 to 2020.
Main Results:
- A total of 8,393 hospitalizations due to STS were recorded.
- Ecuador experienced 7,088 deaths attributed to STS over the decade.
- Pichincha and Guayas provinces reported the highest incidence of STS cases, with a mortality rate ranging from 1.2 to 2.0 per 100,000 people.
Conclusions:
- Soft-tissue sarcomas represent a rare oncological challenge in Ecuador.
- Morbidity and mortality rates for STSs have remained consistent over the last ten years.
- National epidemiological studies are essential to ascertain the true prevalence of STS and to develop targeted interventions aimed at reducing mortality.
Related Concept Videos
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Rous Sarcoma Virus (RSV) and Cancer
5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.3K
Skin Cancer
4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K

